Amyotrophic Lateral Sclerosis Market Outlook 2025-2034

Amyotrophic lateral sclerosis (ALS) market is set for significant growth from 2025 to 2034, driven by increasing disease prevalence, advancements in drug development, and rising healthcare investments. Innovations in gene therapy, stem cell research, and neuroprotective treatments are improving patient outcomes. North America dominates due to strong research funding, while Asia-Pacific sees rising demand with improving healthcare infrastructure. Challenges include high treatment costs and limited curative options, but ongoing research and novel therapies will drive market expansion in the coming years.